VČVelibor Čabarkapa

Velibor Čabarkapa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Velibor Čabarkapa has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Stanislava Nikolić

    Faculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia

    4 shared publications
  • Branislava Ilincic

    Clinical Center of Vojvodina, Center of Laboratory Medicine, Novi Sad + University of Novi Sad, Faculty of Medicine, Department of Pathophysiology and Laboratory Medicine, Novi Sad

    3 shared publications
  • Branislava Ilinčić

    Faculty of Medicine, University of Novi Sad; Center for Laboratory Diagnostics, University Clinical Center of Vojvodina, Novi Sad, Serbia

    3 shared publications
  • Dragana Žuvić

    Faculty of Medicine, University of Novi Sad; Center for Laboratory Diagnostics, University Clinical Center of Vojvodina, Novi Sad, Serbia

    3 shared publications
  • Iva Barjaktarovic

    University of Novi Sad, Faculty of Medicine, Department of General Education Subjects, Novi Sad, Serbia + University Clinical Center of Vojvodina, Center for Laboratory Diagnostics, Novi Sad, Serbia

    3 shared publications
  • Dušan Sedlarević

    Faculty of Medicine, University of Novi Sad; Center for Laboratory Diagnostics, University Clinical Center of Vojvodina, Novi Sad, Serbia

    2 shared publications

Latest Publications

  • Open Access

    Applicability of LDL-cholesterol calculation formulas in hypertriglyceridemia: Insights from the Vojvodina

    by Dragana Žuvić, Stanislava Nikolić, Romana Mijović, Branislava Ilinčić, Aneta Ranđelović-Živković, Dušan Sedlarević, Velibor Čabarkapa

    Background: Low-density lipoproteins cholesterol (LDL-C) is a key parameter for assessing the risk of atherosclerotic cardiovascular disease. Direct measurement of LDL-C is not always possible due to practical or financial reasons, making the use of calculation formulas essential. The aim of this study was to evaluate the applicability of four different formulas proposed by Friedewald, Sampson, Anandaraja, and Martin-Hopkins for calculating LDL-C compared to direct method in patients with serum triglyceride levels from 4.5 to 9.0 mmol/L in the population of Vojvodina. Methods: The retrospective study included 272 subjects whose lipid status parameters were measured between June 2022 and June 2023. LDL-C was determined by the direct method (d-LDL-C) on the Alinity c analyser (Abbott Laboratories, Illinois, USA). Calculated LDL-C values were obtained using the four selected formulas. Results: The average age of participants was 52 years, and the median concentration of triglycerides was 5.48 (4.94-6.58) mmol/L. A statistically significant positive correlation was found between d-LDL-C and all calculated LDL-C (P< 0.001). Linear regression analysis of the data showed the best agreement between d-LDL-C and the Sampson formula (slope=0.97; 95% C I=0.91 - 1.04). The smallest mean difference (MD) was observed between d-LDL-C and the Sampson formula (M D=-0.032). When comparing d-LDL-C and LDL-C values obtained by calculation, only the formula of Sampson et al. did not show a statistically significant difference (P= 0.240). Conclusion: In the studied population of patients with hypertriglyceridemia, the Sampson et al. formula showed the best performance compared with the others tested.

  • Open Access

    Tubular functional capacity and maladaptive parathyroid hormone response in early-stage chronic kidney disease

    by Branislava Ilinčić, Radmila Žeravica, Romana Mijović, Esma Isenović, Dragan Burić, Dragana Žuvić, Velibor Čabarkapa

    Clinical data regarding the interaction between tubular functional capacity (TFC) and maladaptive parathyroid gland response in early-stage chronic kidney disease (CKD) are limited. This study aimed to evaluate the association between parathyroid gland response, measured as intact parathyroid hormone (iPTH) serum concentration (pg/mL) using chemiluminescent microparticle immunoassay, and the dissociation between the decline in glomerular filtration rate (GFR) and TFC, assessed through radionuclide clearances. TFC was evaluated by measuring effective renal plasma flow (mERPF, ml/min/1.73m²) using (131I) Hippurate (131I-H) clearance, while GFR was measured using (99m) Tc-DTPA (mGFR, ml/min/1.73m²). Consecutive participants with preexisting CKD (N=111, female 44%, male 56%) were enrolled and stratified into four groups based on CKD stages (1, 2, 3a, and 3b). Median serum iPTH concentrations significantly differed between Stage 1 [23 (20.4-25.5) pg/mL] and Stage 2 [23.6 (20.5-26.8) pg/mL] compared to Stage 3a [38.1 (34.1-41.9) pg/mL] and Stage 3b [45.8 (39.7-51.9) pg/mL] (p=0.01). In Stage 1, there was a significant positive association between iPTH and mERPF (p=0.003). Conversely, in Stage 3b, iPTH was significantly negatively associated with both mGFR and mERPF (p<0.05 for both). Regression models that included the interaction between CKD stage and either mGFR or mERPF, alongside other predictors (age, CKD stage, body mass index, ionized calcium, and 25-hydroxyvitamin D), revealed significant associations with iPTH (p<0.05 for all variables). The assessment of TFC using 131I-H plasma clearance does not enhance the detection of maladaptive parathyroid gland responses compared to evaluating CKD stage and its relationship with declining glomerular and tubular clearances in early-stage CKD patients.

  • Open Access

    Platelet to lymphocyte ratio in the healthy population of Vojvodina

    by Tanja Šašić-Ostojić, Stanislava Nikolić, Maša Sladojević, Velibor Čabarkapa, Dušan Sedlarević, Dragana Žuvić

    Background: The platelet-to-lymphocyte ratio (PLR) is a simple laboratory index that can be applied in the diagnosis and follow-up of various diseases, particularly those with a primary or accompanying systemic inflammatory component. However, its clinical utility is limited by the absence of established reference intervals in the general population. This study aimed to determine the reference interval for PLR. Methods: This retrospective observational study included 4,672 adults who underwent regular systematic check-ups consisting of clinical examinations and basic laboratory analyses, including a complete blood count (CBC). The PLR reference interval was calculated using Clinical and Laboratory Standards Institute (CLSI) guidelines, which estimate percentiles and their 95% confidence intervals (CI). Verification of the reference interval was performed in a group of 95 healthy adults, matched by age and sex to the study cohort. Results: The mean age of participants was 43± 10 years, with a predominance of males (83.7% ). The median PLR was 109 (25th percentile: 90; 75th percentile: 131). The lower limit of the reference interval was 62 (95% CI: 61-63), and the upper limit was 194 (95% CI: 188-198). Female participants had significantly higher PLR values compared with males (P < 0.0001), while elderly participants had significantly lower PLR values compared with the middle-aged and younger groups (P= 0.019). The determined reference interval was 70-231 for females and 61-183 for males. PLR values did not differ significantly between the primary study group and the validation group [108.0 (87-136) vs. 109.0 (90-131); P> 0.05]. Conclusions: In this representative sample, consisting primarily of young and middle-aged adults, the PLR reference interval was 70-231 for women and 61-183 for men. In individuals older than 65 years, PLR values may be lower.

  • Open Access

    Determination of systemic inflammatory biomarkers in multiple sclerosis

    by Maša Sladojević, Stanislava Nikolić, Željko Živanović, Svetlana Simić, Lorand Sakalaš, Igor Spasić, Branislava Ilinčić, Velibor Čabarkapa

    Background: Multiple sclerosis (MS) is one of the most common demyelinating diseases of the central nervous system. We aimed to investigate serum and cerebrospinal fluid levels of different laboratory inflammatory biomarkers in patients with MS. Methods: A total of 120 subjects participated in the study, 60 of whom were diagnosed with MS, 30 with the final diagnosis of non-inflammatory diseases of the central nervous system (CNS), and 30 healthy subjects representing the control group. Regarding the progression of radiological findings after 2 years from the initial diagnosis, the MS group was divided into stationary radiological findings (n=30) and radiologically proven disease progression (n=30). In all patients, we analyzed levels of laboratory inflammatory biomarkers: C reactive protein (CRP), Neutrophil-to-lymphocyte ratio (NLR), Growth differentiation factor 15 (GDF15) in serum samples, and neurofilaments (NFs) in cerebrospinal fluid (CSF). NFs and GDF15 were analyzed initially, while CRP and NLR values were analyzed initially and after two years. Results: We found statistically lower GDF15 values and initial CRP values in the MS group regarding the group with non-inflammatory diseases of the CNS (p<0.0001). On the other side, we determined a significant elevation of laboratory markers CRP and NLR, initially and after a two-year period, in the MS subgroup with the progression of magnetic resonance imaging (MRI) findings (p<0.0001 and p=0.050, respectively). Also, we found a positive correlation between CRP and NFs (r=0.243, p=0.04), as well as a positive correlation between CRP and GDF15 in patients with MS (r=0.769, p<0.0001). Conclusions: We found a significant elevation of laboratory markers of systemic inflammation, CRP, and NLR in MS patients who developed disease progression based on MRI findings. There is a need for further studies to validate current parameters to be considered as useful markers of MS activity and disability.


  • Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?

    by Danijela Agić, Velibor Čabarkapa, Ivana Milošević, Ivanka Perčić, Amir El Farra, Stanislava Nikolić, Borivoj Sekulić, Nada Vlaisavljević, Aleksandar Savić, Ivana Urošević, et al.

    Growth and differentiation factor-15 (GDF-15) correlates with worse outcome of many tumours and any cause mortality. Data about its role in lymphoproliferative neoplasms (LPN) are scarce. Our research aimed to reveal the correlation between GDF-15 and standard laboratory parameters of LPN activity, and to get insight into the possible value of this cytokine assessment in lymphoma patients. Prospective research included 40 patients treated for aggressive or indolent LPN, and 31 with indolent LPN on “watch and wait” regimen. Analyses were performed before and after treatment in treated patients and on two separate occasions in the “watch and wait” group. ELISA technique with R&D assays according to the manufacturer manual, from stored sera at − 70 °C was used for GDF-15 level measurement. Statistical analyses were performed by IBM SPSS Statistics 22 using descriptive and inferential statistics. As appropriate, differences between groups were assessed by two tailed t-test, Mann–Whitney or x2 test. Spearman Rank Order Correlation was done to correlate GDF-15 with standard laboratory markers of disease activity. All tests are two-tailed with significance level p < 0. 05. GDF-15 (p = 0.028) and fibrinogen (p = 0.001) concentrations increased after treatment in indolent lymphoma patients while β2 microglobulin decreased (p < 0.001). GDF-15 positively correlated with β2microglobulin before (p < 0.001) and after (p = 0.031) therapy. There were no differences in any of the aforementioned parameters in the “watch and wait” group during observation. A positive correlation between GDF-15 and β2 microglobulin in patients with indolent LPN who need treatment suggests potential value in risk assessment.

  • Open Access

    Comparison of diagnostic efficacy of the Abbott RealTime SARS-CoV-2 assay and the BGI real-time fluorescent RT-PCR kit for the RT-PCR-based detection of Severe Acute Respiratory Syndrome Coronavirus-2

    by Jelena Stojcevic-Maletic, Iva Barjaktarovic, Katarina Baculov, Velibor Cabarkapa, Vladimir Sakac, Zoran Gojkovic

    Introduction/Objective. Based on the World Health Organization guidelines, the current "gold standard" to diagnose Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR). The objective of this study was to compare and analyze the detection performance of two different authorized SARS-CoV-2 nucleic acid detection assays: the Abbott RealTime SARS-CoV-2 (ACOV) assay and the BGI Real-Time Fluorescent RT-PCR (BGI) kit. Methods. Our study included 384 randomly selected nasopharyngeal and oropharyngeal swabs previously tested by the ACOV and subsequently tested by the BGI kit for detecting SARS-CoV-2. All patients were adult individuals with symptoms or suspected of Coronavirus disease 2019 (COVID-19). Results. We found that the ACOV assay detected more cases of COVID-19 infection than the BGI assay. The positive percent agreement was 98.3% (95% confidence intervals (95% CI): 95.7-99.3%), while Cohen’s Kappa coefficient (Kappa) was 0.86 (95% CI: 0.80-0.91), indicating a strong level of agreement between these two tests. The negative percent agreement was 85.1% (95% CI: 78.3-90%), while 5.47% of cases were false negative using the BGI test to detect SARS-CoV-2. The sensitivity of the BGI test compared to Abbott was 91.73% (95% CI: 87.64-94.81%), and the specificity of the BGI test was 96.77% (95% CI: 91.95-99.11%). Conclusion. The Abbott kit showed a bit better diagnostic performance, and due to possible false negative results using the BGI test, we recommend complete testing with the ACOV test.


  • Diagnosing COVID-19: diagnostic importance of detectingEgene of the SARS-CoV-2 genome

    by Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa

    Aim: To evaluate the significance of E gene analysis in addition to N and RdRp genes of SARS-CoV-2, and to compare the specificity and sensitivity of targets. Materials & methods: We used two reverse transcription-PCR assays: one targeting N, E and RdRp and the other targeting N and RdRp genes and analyzed variation in threshold cycle (Ct) values. Results: Of the 155 samples, 70.32% tested positive: all three genes were detected in 45.87%, N and RdRp in 19.27% and only N in 34.86%. Patients negative for the E gene were tested after symptoms disappeared and Ct values were significantly higher. Conclusion: Samples negative for the E gene were potentially false positive and clinical conditions should be assessed while interpreting results.


  • Status of tryptophan metabolites in different stages of chronic kidney disease of non-diabetc etiology

    by Ivana Isakov, Velibor Cabarkapa, Branislava Srdjenovic-Conic, Nebojsa Kladar, Branislava Ilincic, Dragan Buric

    Introduction. Modification of tryptophan metabolism during the progression of chronic kidney disease may have significant pathophysiological consequences. The aim of this study was to investigate the status of metabolic products of tryptophan, indoxyl sulfate and kynurenine in different stages of chronic kidney disease. Material and Methods. In all participants included in the cross-sectional study (n = 66) with previously diagnosed chronic kidney disease, the parameters of renal function were measured: glomerular filtration rate using radionuclide plasma clearance with 99mTc-labelled diethylene triamine penta-acetate and effective renal plasma flow using 131Ilabeled orthoiodohippuric acid. Plasma concentrations of indoxyl sulfate and kynurenine were measured by high-performance liquid chromatography. Results. A significant difference was observed in the concentrations of both metabolites between the observed groups (Group II - measured glomerular filtration rate - 15 - 60 ml/min/1.73 m?; n = 36 vs. Group I measured glomerular filtration rate > 60 l/ min/1.73 m?; n = 26): indoxyl sulfate 1.07 ? 0.89 vs. 2.44 ? 4.05 ?g/ ml, p < 0.001; kynurenine 3.15 ? 0.22 vs. 3.21 ? 0.17 ?g/ml, p < 0.05. The correlation was statistically significant between glomerular filtration rate and kynurenine - r = -0.38, p = 0.001 and indoxyl sulfate - r = 0.56, p ? 0.001; effective plasma renal flow and kynurenine - r = -0.33, p < 0.05 and indoxyl sulfate - r = 0.46, p ? 0.001. Conclusion. There is a significant difference in the plasma concentrations of indoxyl sulfate and kynurenine in the group of patients with glomerular filtration rate of 15 - 60 ml/min/1.73 m? compared to patients with glomerular filtration rate > 60 ml/min/1.73 m?. In patients with chronic kidney disease, plasma concentrations of both metabolites of tryptophan are inversely correlated with the glomerular filtration rate and effective plasma renal flow.


  • Open Access

    Comparison of abbott Real Time SARS-COV-2 ASSAY, Genefinder™ Covid-19 plus realamp kit and Biomerieux Argene® SARS-COV-2 R-Gene® kit for the RT-PCR based detection of SARS-COV-2 from nasopharyngeal swabs

    by Jelena Stojcevic-Maletic, Iva Barjaktarovic, Vanja Radenkovic, Velibor Cabarkapa

    Early, rapid and reliable identification of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is crucial for successful control of coronavirus disease 2019 (COVID-19). The quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) assay is considered the gold standard for molecular diagnosis of SARS-CoV-2. The objective of this study was to compare the clinical performances of the three authorized tests - the Abbott Real Time SARS-CoV-2 (ACOV) assay (Abbott Molecular Inc., North Chicago, IL), GeneFinder™ COVID-19 Plus RealAmp (GeneFinder) Kit (OSANG Healthcare Co., Ltd, Dongan-gu Anyang, Korea) and the Biomerieux ARGENE® SARS-COV-2 R-GENE® real-time detection (ARGENE) kit (bioMérieux SA., Marcyl’Étoile, France) and to determine whether the selection of targeted genes has an impact on test's specificity. In this study, we included 155 nasopharyngeal swabs (NPS) from adult individuals with symptoms or suspected of COVID-19, aged from 17 to 91 years, previously tested by the ACOV and subsequently tested by the GeneFinder and the ARGENE. In this comparative analysis, we found that the GeneFinder assay detected the most cases of COVID-19 infection, followed by the ACOV assay, and then by ARGENE. Positive agreement ranged from 74.74% to 95.41%, with the strongest agreement observed between the GeneFinder and ACOV assays - 95.41% (95% confidence intervals (CI): 89.37%-98.36%) indicating an excellent agreement between these two tests and the lowest agreement between the GeneFinder and ARGENE assay - 74.74% (95% CI: 65.08%-81.41%). The negative percent agreement was 100% (GeneFinder/ACOV, GeneFinder/ARGENE and ACOV/ARGENE). Only 3.2% of cases were false-negative using the ACOV test, while 18.0% of samples were false-negative using the ARGENE assay to detect SARS-CoV-2. Combined usage of the Abbott SARS-CoV-2 and the GeneFinder assays can be applied to maximize SARS-CoV-2 detection accuracy.

  • Hematological parameters in children with severe acute respiratory syndrome coronavirus 2 infection

    by Dejan Dobrijevic, Biljana Vuckovic, Jasmina Katanic, Goran Rakic, Jelena Antic, Velibor Cabarkapa

    Introduction. Recently, there has been a need to use more readily available parameters to assess the severe acute respiratory syndrome coronavirus 2 infection in children. Material and Methods. A single-center retrospective study included 30 children with severe acute respiratory syndrome coronavirus 2 infection who were admitted to the Isolation Department of the Institute for Child and Youth Health Care of Vojvodina from April to September 2020. A complete blood count with differential was performed. Additionally, systemic inflammatory index, neutrophil-lymphocyte ratio and plateletlymphocyte ratio were calculated. For comparison, age- and sex-matched 30 children negative for severe acute respiratory syndrome coronavirus 2 were included in the study. Results. In the period from April to September 2020, 30 laboratory-confirmed cases of coronavirus-19, aged 0 - 17 years, were admitted to the Institute for Child and Youth Health Care of Vojvodina. The age was not a risk factor for the development of coronavirus-19 (p = 0.707; OR: 1.018; 95% CI: 0.927 - 1.119). The comparison of hematological parameters of severe acute respiratory syndrome coronavirus 2 status showed that hemoglobin concentration (p < 0.01) and hematocrit (p < 0.01) were lower, and the percentage of neutrophil granulocytes (p < 0.05) was higher among severe acute respiratory syndrome coronavirus 2 positive children. Furthermore, it was found that some severe acute respiratory syndrome coronavirus 2 positive children had a higher (p < 0.01), while others had a lower (p < 0.01) percentage of lymphocytes. The systemic inflammatory index, the ratio of neutrophils to lymphocytes, and the ratio of platelets to lymphocytes, were not found to be statistically significantly different (p > 0.05). Conclusion. Low hemoglobin and hematocrit levels, a high percentage of neutrophil granulocytes, and a non-physiological percentage of lymphocytes (both, low and high) may have a diagnostic significance in children with severe acute respiratory syndrome coronavirus 2 infection.